Is a complete GTBP research report available?

No complete published report is available for GT Biopharma, Inc. (GTBP) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

GT Biopharma, Inc. (GTBP)

NASDAQ: GTBP · USD

$0.31

+0.01 (+2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first GTBP analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	11.1M
Net income (ttm)	-37M
EPS (ttm)	-$2.96
Shares out	36.1M
Volume	457,716
Beta	0.84

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -37M
EPS (ttm): -$2.96
Market cap: 11.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All GTBP indicators

Market & fundamental data

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000109657
Company name	GT Biopharma, Inc.
Country	United States
Country code	US
Cusip	36254L308
Employees	1
Employees Change	-1%
Employees Change Percent	-50
Enterprise value	$2.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US36254L3087
Last refreshed	2026-07-31
Market cap	$11.1M
Market cap category	Nano-Cap
Price	$0.31
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	GTBP
Website	https://www.gtbiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-331.02%
FCF yield	-117.78%
P/B ratio	1.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-37M
Net Income Growth Years	0%
Profit Per Employee	$-37M
ROA	-131.8
Roa5y	-104.6
ROCE	-176
ROE	-921.5
ROIC	-252.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-68.2%
Cagr15y	-66.34%
Cagr1y	-84.93%
Cagr20y	-57.96%
Cagr3y	-66.86%
Cagr5y	-75.39%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$10M
Cash	$8.9M
Current Assets	$10M
Current Liabilities	$2.4M
Debt	$0
Equity	$7.6M
Interest Coverage	-70.2
Liabilities	$2.4M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$8.9M
Net Cash By Market Cap	$79.74
Net Cash Growth	277.29%
Net Debt Equity	$-1.18
Tangible Book Value	$7.6M
Tangible Book Value Per Share	$0.22
WACC	8.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.14
Net Working Capital	$-1.3M
Quick ratio	3.69
Working Capital	$7.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-484.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-84.91%
200-day SMA	0.53
3Y total return	-96.36%
50-day SMA	0.42
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.91%
All Time High	1,634,615,384.6
All Time High Change	-100%
All Time High Date	1991-11-08
All Time Low	0.26
All Time Low Change	17.93%
All Time Low Date	2026-04-29
ATR	0.04
Beta	0.84
Beta1y	1.38
Beta2y	0.78
Ch YTD	-60.8
High	0.32
High52	2.11
High52 Date	2025-07-30
High52ch	-85.41%
Low	0.3
Low52	0.26
Low52 Date	2026-04-29
Low52ch	17.93%
Ma50ch	-26.73%
Premarket Change Percent	-0.27
Premarket Price	$0.3
Premarket Volume	1,358
Price vs 200-day SMA	-41.96%
RSI	35.46
RSI Monthly	37.08
RSI Weekly	33.66
Sharpe ratio	-0.91x
Sortino ratio	-1.28
Total Return	-484.42%
Tr YTD	-60.8
Tr15y	-100%
Tr1m	-30.05%
Tr1w	-8.17%
Tr3m	13.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.08
Operating Income	$-13.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,468,705%
Float Percent	92.81%
Shares Insiders	6.94%
Shares Institutions	5.76%
Shares Out	36,062,904
Shares Qo Q	133.34%
Shares Yo Y	484.42%
Short Float	14.3%
Short Ratio	3.54
Short Shares	13.27

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-13.7M
Adjusted OCF	-13,655,000
Average Volume	790,899.3x
Bv Per Share	0.22
Ch10y	-100
Ch15y	-100
Ch1m	-30.05
Ch1w	-8.17
Ch1y	-84.91
Ch20y	-100
Ch3m	13.16
Ch3y	-96.36
Ch5y	-99.91
Ch6m	-54.74
Change	1.99%
Change From Open	-0.68
Close	0.3
Days Gap	2.68
Dollar Volume	140,885
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-13.3M
EBITDA	$-13.3M
EPS	$-2.96
F Score	2
FCF	$-13.2M
FCF EV Yield	-581.3x
FCF Per Share	$-0.37
Financing CF	19,739,000
Fiscal Year End	December
Founded	1,965
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2024-02-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-02
Ma150	0.48
Ma150ch	-35.43%
Ma20	0.38
Ma20ch	-18.7%
Net CF	6,559,000
Next Earnings Date	2026-08-13
Open	0.31
Optionable	No
Position In Range	40.41
Post Close	0.31
Postmarket Change Percent	1.01
Postmarket Price	$0.31
Pre Close	0.3
Price Date	2026-07-30
Ptbv Ratio	1.48
Relative Volume	0.58x
Share Based Comp	475,000
Tr20y	-100%
Tr6m	-54.74%
Us State	California
Volume	457,716

GT Biopharma, Inc. (GTBP)

Coverage state: Market snapshot only — no published research

Generate the first GTBP analysis

Price

Financial snapshot

Fair-value bridge

Latest news · GTBP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GTBP indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on GTBP

Frequently asked questions